PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.30%
Revenue growth above 1.5x TSM's 0.52%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.08%
Gross profit growth above 1.5x TSM's 0.52%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
26.27%
EBIT growth above 1.5x TSM's 0.52%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
26.27%
Operating income growth above 1.5x TSM's 0.52%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
24.62%
Net income growth above 1.5x TSM's 0.52%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
157.14%
EPS growth above 1.5x TSM's 1.52%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
150.00%
Diluted EPS growth above 1.5x TSM's 1.52%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-48.95%
Share reduction while TSM is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-49.43%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-26.53%
Negative OCF growth while TSM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-32.27%
Negative FCF growth while TSM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
82.27%
10Y revenue/share CAGR at 75-90% of TSM's 104.49%. Bill Ackman would press for new markets or product lines to narrow the gap.
82.27%
5Y revenue/share CAGR at 75-90% of TSM's 104.49%. Bill Ackman would encourage strategies to match competitor’s pace.
82.27%
3Y revenue/share CAGR 1.25-1.5x TSM's 70.87%. Bruce Berkowitz might see better product or regional expansions than the competitor.
50.24%
OCF/share CAGR of 50.24% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
50.24%
OCF/share CAGR of 50.24% while TSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
50.24%
3Y OCF/share CAGR of 50.24% while TSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
136.25%
Positive 10Y CAGR while TSM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
136.25%
Positive 5Y CAGR while TSM is negative. John Neff might view this as a strong mid-term relative advantage.
136.25%
Positive short-term CAGR while TSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
227.76%
Equity/share CAGR of 227.76% while TSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
227.76%
Equity/share CAGR of 227.76% while TSM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
227.76%
Equity/share CAGR of 227.76% while TSM is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.63%
AR growth of 22.63% while TSM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
36.78%
Inventory growth of 36.78% while TSM is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
93.88%
Asset growth of 93.88% while TSM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
243.60%
BV/share growth of 243.60% while TSM is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
16866.72%
Debt growth of 16866.72% while TSM is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
9.34%
R&D growth of 9.34% while TSM is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
1.71%
SG&A growth of 1.71% while TSM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.